Offer - Urjas Oil for just ₹ 1
Zolnite is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Insomnia.
The right dosage of Zolnite depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Zolnite include Sleepiness, Dizziness, Nervousness. While these are the most often observed Zolnite side effects, there are can be others also. These have been listed below. These side effects of Zolnite are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Zolnite's effect during pregnancy is Moderate and Severe while nursing. Further, the section on Zolnite related warnings talks about Zolnite's effects on the liver, heart and kidney.
Zolnite can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Zolnite in conditions like Depression, Suicidal Tendency. Some other conditions that can be affected by Zolnite are listed in the contraindications section below.
Besides this, Zolnite may also have severe interaction with some medicines. See below for a complete list.
You should also be aware that Zolnite is not safe while driving, and is not addiction.
Zolnite is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Zolnite safe for pregnant women?
Zolnite may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Zolnite again without your doctor's advice.
Is the use of Zolnite safe during breastfeeding?
Zolnite should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Zolnite on the Kidneys?
There may be some adverse effects on kidney after taking Zolnite. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Zolnite on the Liver?
You may experience side effects on your liver after taking Zolnite. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Zolnite on the Heart?
Zolnite is rarely harmful for the heart.
Zolnite should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Zolnite unless your doctor advises you to do so -
Is this Zolnite habit forming or addictive?
Zolnite is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Zolnite as you may feel sleepy.
Is it safe?
Yes, but consume Zolnite only on doctor's advice.
Is it able to treat mental disorders?
No, Zolnite is not used to treat mental disorders.
Interaction between Food and Zolnite
There isn't any research available on the side effects of taking Zolnite with food.
Interaction between Alcohol and Zolnite
It is difficult to say anything about the effect of Zolnite and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lunesta® (eszopiclone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 406
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 532-533
